Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Pain 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphoma 1Leukemia 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 42fludarabine phosphate 33Peripheral Blood Stem Cell Transplantation 31Busulfan 31Tacrolimus 24Antilymphocyte Serum 24Cyclosporine 22Mycophenolic Acid 20Filgrastim 20Radiotherapy 19Methotrexate 19Melphalan 17Whole-Body Irradiation 13Methylprednisolone 12Etoposide 12Cord Blood Stem Cell Transplantation 11Cytarabine 9Sirolimus 7Flow Cytometry 7Azacitidine 7Alemtuzumab 7Specimen Handling 6Psychiatric Rehabilitation 6Cyclosporins 6Biopsy 6sargramostim 5ruxolitinib 5Thiotepa 5fludarabine 4Rituximab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Myelodysplastic-Myeloproliferative Diseases × Baclofen × Clear all
NCT00516503 2017-08-24

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
208 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Pain, Neurotoxicity Syndromes, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡